Header Logo

Connection

Srinivas Vourganti to Prostatic Neoplasms, Castration-Resistant

Back to Details
This is a "connection" page, showing publications Srinivas Vourganti has written about Prostatic Neoplasms, Castration-Resistant.
Srinivas Vourganti
Connection Strength
0.212
Prostatic Neoplasms, Castration-Resistant
  1. Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol. 2022 08 01; 8(8):1128-1136.
    View in: PubMed
    Score: 0.212
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.